Allergen Deal with Tribe Faces Backlash


The September decision by the Allergen drug company to enter into a contract with the St. Regis Tribal Council to protect its Restasis eye drug patent is drawing fire from members of the US Congress who are introducing legislation to strip all Nat...

For access to this article please sign in or subscribe.


Reader Comments(0)


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2021